Inseonmedics Inc.

Inseonmedics Inc. is a for-profit corporation registered in SAM.gov that specializes in providing specialized medical reagents for diagnostic and laboratory purposes, primarily serving U.S. military healthcare facilities in South Korea. The company focuses on supplying VENTANA HE600 reagents, which are critical consumables used in immunohistochemistry staining platforms for supporting military healthcare and biological defense programs. While limited background information is available, the company appears to be a strategic supplier of specialized laboratory equipment and supplies to U.S. defense medical facilities, with a particular emphasis on overseas military medical infrastructure.

The company has consistently provided VENTANA HE600 reagents through multiple federal contract awards, exclusively working with defense-related agencies such as the Defense Health Agency and Department of the Army Medical Command. These contracts have been exclusively focused on supplying diagnostic reagents for the Brian D. Allgood Army Community Hospital laboratory and Biological Defense Automated Analytical Platform in South Korea. All of the company's federal contract awards have been non-set-aside contracts, indicating open competition. The delivery orders have ranged from $10,267 to $45,000, with a cumulative value of over $200,000 across multiple fiscal years. Inseonmedics Inc. has functioned as a prime contractor in these arrangements, with no subcontractors mentioned in the contract documentation.

Inseonmedics Inc. holds a single-award indefinite delivery contract (IDV) with the Defense Health Agency, identified as W81K0220D0003, with a potential ceiling value of $649,470 through September 30, 2024. This IDV is specifically designed to provide VENTANA HE600 reagents supporting histopathology analysis and biological defense operations in medical facilities located in the Republic of Korea. Under this IDV, the company has received five firm-fixed-price delivery orders between fiscal years 2020-2024, totaling $204,456. The contract originated from a pre-solicitation seeking a vendor capable of supplying various specialized laboratory solutions, including wash solutions, hematoxylin, bluing solution, eosin, and other diagnostic consumables compatible with the VENTANA HE600 platform. The IDV demonstrates the company's specialized role in maintaining laboratory testing capabilities for U.S. military medical facilities in an overseas context.